VRCA
Verrica Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.30
−1.12%Leverage
- Debt / equity
- 0.42x
- Net debt / equity
- -2.18x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 0.35x
Liquidity & coverage
- Current ratio
- 1.45x
- Quick ratio
- 1.33x
- Cash ratio
- 0.50x
- Interest coverage
- -7.54x
- EBITDA / interest
- -7.20x
- Working capital
- $10.2M
Cash & dividend
- FCF / debt
- -7.37x
- Cash flow / debt
- -7.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026